Control preconcepcional de la paciente diabética

Hernández, Jeddú Cruz; Prieto, Jacinto Lang; Guillén, Antonio Márquez

doi:10.1590/s0864-34662007000400010

Cited by 2 publications

(2 citation statements)

References 4 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…G DM is the most common endocrine disorder of pregnancy and its definition has changed over time. Since 2015, the American Diabetes Association (ADA) defined GDM as diabetes diagnosed in the second or third trimester of pregnancy that was not clearly overt diabetes prior to gestation based on the perception that early GDM frequently represents undiagnosed pre-pregnancy diabetes (1)(2)(3)(4). Therefore, GDM definition, particularly in early pregnancy, remains a controversial issue.…”

Section: Introductionmentioning

confidence: 99%

“…GDM prevalence has been rising presumably due to the influence of factors such as the delay of childbearing (≥30 years) and obesity (2). Women with GDM are at increased risk of preeclampsia, cesarean delivery and future type 2 DM while their infants tend to have higher rates of macrosomia (birth weight >4,000g) and shoulder dystocia (6,7).…”

Section: Introductionmentioning

confidence: 99%

See 1 more Smart Citation

Body mass index and gestational weight gain: relevance in gestational diabetes and outcomes - A retrospective cohort study

Rosinha¹,

Dantas²,

Alves³

et al. 2022

Archives of Endocrinology and Metabolism

View full text Add to dashboard Cite

Objective: To evaluate the influence of maternal pre-pregnancy body mass index (BMI) and gestational weight gain (GWG) on blood glucose levels at diagnosis of gestational diabetes mellitus (GDM) and obstetric/neonatal outcomes. Subjects and methods: Retrospective cohort study including 462 women with GDM and singleton pregnancy delivered in our institution between January 2015 and June 2018 and grouped according to BMI/GWG. Results: The diagnosis of GDM was more likely to be established in the 1 st trimester (T) in women with obesity than in normal-weight (55.8% vs 53.7%, p = 0.008). BMI positively and significantly correlated with fasting plasma glucose (FPG) levels in the 1 st T (rs = 0.213, p = 0.001) and 2 nd T (rs = 0.210, p = 0.001). Excessive GWG occurred in 44.9% women with overweight and in 40.2% with obesity (p < 0.001). From women with obesity, 65.1% required pharmacological treatment (p < 0.001). Gestational hypertension (GH) was more frequent in women with obesity (p = 0.016). During follow-up, 132 cesareans were performed, the majority in mothers with obesity (p = 0.008). Of the 17 large-for-gestational-age (LGA) birthweight delivered, respectively 6 and 9 were offsprings of women with overweight and obesity (p = 0.019). Maternal BMI had a predictive value only for macrosomia ), p = 0.041]. BMI and GWG positively correlated with birthweight (rs = 0.132, p = 0.005; rs = 0.188, p = 0.005). Conclusion: Maternal obesity is related with a major probability of diagnosis of GDM in 1 st T, fasting hyperglycemia in 2 nd T and a more frequent need for pharmacological therapy. Pre-gestational obesity is associated with GH, cesarean delivery and fetal macrosomia.

show abstract

Section: Introductionmentioning

confidence: 99%